Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The protein p21 (WAF1, CIP1 or sdi1), induced by the tumour-suppressor protein p53, interacts with and inhibits two different targets essential for cell-cycle progression. One of these is the cyclin-Cdk family of kinases and the other is the essential DNA replication factor, proliferating-cell nuclear antigen (PCNA). We report here that separate domains of p21 are responsible for interacting with and inhibiting the two targets. An amino-terminal domain inhibits cyclin-Cdk kinases and a carboxy-terminal domain inhibits PCNA. Using these separated domains, we have determined that p21 inhibits different biological systems through different targets. The PCNA-binding domain is sufficient for inhibition of DNA replication based on simian virus 40, whereas the Cdk2-binding domain is sufficient for inhibition of DNA replication based on Xenopus egg extract and for growth suppression in transformed human cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“P21 functions primarily by binding to and inhibiting CDKs, and in addition, p21 halts the cell cycle by blocking PCNA, which is required for DNA replication.150, 151”
From Census and evaluation of p53 target genes (2017) · cites this paper as [151]
In the citing paper
“P21 functions primarily by binding to and inhibiting CDKs, and in addition, p21 halts the cell cycle by blocking PCNA, which is required for DNA replication.150, 151”
From Census and evaluation of p53 target genes (2017) · cites this paper as [151]
In the citing paper
“When assessing the effect of p21 on PCNA-dependent DNA synthesis in cells, several reports showed a limited or null effect of p21–PCNA interaction on DNA replication [38,45,46,47,48,49,50,51].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [49]
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
El‐Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Ce, C., Jackman, J., Pietenpol, J. A., Burrell, M., De, H., & Wang, Y. (1994) · PubMed · Cited by 2,336
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655
Dulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., & Smith, J. R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1063 · Cited by 1,351
Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit
Gu, Y., Turck, C. W., & Morgan, D. O. (1993) · Nature · doi:10.1038/366707a0 · Cited by 764
Research works printed but not linked: 1
- el-Deiry, W. et al. Cancer Res. 54, 1169–1174 (1994).
Cited by
Items 301–400 of 548
Xu, Y., Wang, X., Gao, L., Zhu, J., Zhang, H., Shi, H., Woo, M., & Wu, X. (2015) · Diabetologia · doi:10.1007/s00125-015-3670-0 · Cited by 40
“p21 is the target gene of p53, and p21 protein serves not only as a cell cycle inhibitor [33, 34] but also as a promoter of cell cycle progression [35, 36], promoting mitosis by forming a complex with caspase-3 and survivin [37].”
BackgroundWang, Y., Gu, X., Zhang, G., Wang, L., Wang, T., Zhao, Y., Zhang, X., Zhou, Y., Kadin, M. E., & Tu, P. (2014) · Blood · doi:10.1182/blood-2013-10-534693 · Cited by 35
Prognostic Significance of p21WAF1/CIP1 Expression in Tongue Squamous Cell Carcinomas
Xie, X., Clausen, O. P. F., & Boysen, M. (2002) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.128.8.897 · Cited by 35
“In addition, p21 may block DNA synthesis by direct binding to the proliferating cell nuclear antigen that is important in DNA replication.(6,7) The levels of p21 may also be elevated by non– p53-dependent mechanisms.”
Shiraishi, K., Naito, K., & Yoshida, K. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)65831-4 · Cited by 36
Kawata, S., Ariumi, Y., & Shimotohno, K. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7291-7299.2003 · Cited by 35
Winter, J. N., Li, S., Aurora, V., Variakojis, D., Nelson, B. P., Krajewska, M., Zhang, L., Habermann, T. M., Fisher, R. I., Macon, W. R., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1219 · Cited by 37
“p21 inhibits cell cycle progression through its inhibition of cyclin-dependent kinase–cyclin complexes and proliferating cell nuclear antigen (34, 35).”
BackgroundYoon, M., Venkatachalam, V., Huang, A., Choi, B., Stultz, C. M., & Chou, J. J. (2009) · Protein Science · doi:10.1002/pro.34 · Cited by 44
Tannoch, V. J., Hinds, P. W., & Tsai, L. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46817-4_12 · Cited by 40
Cell Cycle Control in Fission Yeast and Mammals: Identification of New Regulatory Mechanisms
Okayama, H., Nagata, A., Jinno, S., Murakami, H., Tanaka, K., & Nakashima, N. (1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60859-3 · Cited by 34
Tumor Suppressor Genes and Human Cancer
Brown, M. A. (1997) · Advances in genetics · doi:10.1016/s0065-2660(08)60307-7 · Cited by 39
The tumor suppressor p53 modifies mutational processes in a human lymphoblastoid cell line
Xia, F., & Liber, H. L. (1997) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(96)00193-5 · Cited by 31
Yates, S. C., Zafar, A., Rabai, E. M., Foxall, J. B., Nagy, S., Morrison, K. E., Clarke, C., Esiri, M. M., Christie, S., Smith, A. D., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0114050 · Cited by 31
“P21 has a number of additional cellular functions, such as DNA replication and repair [60] and the prevention of apoptosis [61].”
BackgroundYuan, J., Li, X., Zhang, G., Cheng, W., Wang, W., Lei, Y., Ma, Q., & Song, G. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23290 · Cited by 29
Adeyemi, R. O., & Pintel, D. J. (2012) · Journal of Virology · doi:10.1128/jvi.00820-12 · Cited by 33
“p21 has at least two critical interacting cellular partners that affect DNA replication, a cyclin-dependent kinase (CDK) binding site in the N terminus and a C-terminal PCNA interaction motif (9, 29).”
BackgroundMcShea, A., Samuel, T., Eppel, J.-T., Galloway, D. A., & Funk, J. O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001772200 · Cited by 37
Zang, Y., Tai, Y., Wan, B., & Jia, X. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2758 · Cited by 33
“…of CRMP1 downregulated p53 protein expression in TE2 EC cells. p21-mediated growth inhibition has been attributed to two main activities that depend on two non-overlapping structural domains: the carboxy-terminal PCNA-binding domain and the amino-terminal CDK-cyclin inhibitory domain (33,34).”
Increased double strand breaks in diabetic β-cells with a p21 response that limits apoptosis
Tay, V. S. Y., Devaraj, S., Koh, T., Ke, G., Crasta, K., & Ali, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-54554-8 · Cited by 31
HIV-1 Vpr and p21 restrict LINE-1 mobility
Kawano, K., Doucet, A. J., Ueno, M., Kariya, R., An, W., Marzetta, F., Kuroki, M., Turelli, P., Sukegawa, S., Okada, S., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky688 · Cited by 29
“transfected with pcDNA3, pcDNA3p21 (56), pcDNA3p21N (56), pcDNA3p21C or pcCMXp27.”
BackgroundInfluentialResveratrol and its impact on aging and thyroid function.
Duntas, L. H. (2011) · PubMed · doi:10.3275/7926 · Cited by 29
Corroyer, S., Schittny, J. C., Djonov, V., Burri, P. H., & Clément, A. (2002) · Pediatric Research · doi:10.1203/00006450-200202000-00008 · Cited by 31
Li, J. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i28.4363 · Cited by 29
A new p21waf1/cip1 isoform is an early event of cell response to oxidative stress
Esposito, F., Cuccovillo, F., Russo, L., Casella, F., Russo, T., & Cimino, F. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400427 · Cited by 30
“In addition to the well-defined aminoterminal cyclin- and CDK-binding motifs (Chen et al, 1995; Chen J et al, 1996), a binding site for the proliferating cell nuclear antigen (PCNA) is present at the C-terminus of p21 protein (Gulbis et al, 1996).”
BackgroundTournier, S., Leroy, D., Goubin, F., Ducommun, B., & Hyams, J. S. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.4.651 · Cited by 30
Regulation of cyclin E and p27kip during mitosis in BALB/c 3T3 cells.
Agrawal, D., Dong, F., Wang, Y., Kayda, D. B., & Pledger, W. J. (1995) · PubMed · Cited by 29
Gu, M., & Brecher, P. I. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.1.27 · Cited by 29
Small-Molecule Inhibitors of Cyclin-Dependent Kinases: Molecular Tools and Potential Therapeutics
Walker, D. H. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-71941-7_8 · Cited by 34
A Low Abundance Pool of Nascent p21WAF1/Cip1 Is Targeted by Estrogen to Activate Cyclin E·Cdk2
Prall, O. W. J., Carroll, J. S., & Sutherland, R. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104752200 · Cited by 31
Ionizing radiation induces ATM-independent degradation of p21Cip1 in transformed cells
Stuart, S. A., & Wang, J. Y. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808810200 · Cited by 28
Yamamoto, S., Kohsaka, S., & Nakajima, K. (2012) · Glia · doi:10.1002/glia.22291 · Cited by 29
“The CdkI proteins interact with a variety of cyclin/Cdk complexes through a conserved N-terminal domain containing both cyclin- and Cdk-binding sites (Chen et al., 1995; Luo et al., 1995).”
BackgroundThe Role of Vpr in the Regulation of HIV-1 Gene Expression
Cui, J., Tungaturthi, P. K., Ayyavoo, V., Ghafouri, M., Ariga, H., Khalili, K., Srinivasan, A., Amini, S., & Sawaya, B. E. (2006) · Cell Cycle · doi:10.4161/cc.5.22.3442 · Cited by 31
“These observations suggest that residues (1-90) and (149-164) of p21 are critical for Vpr association.”
BackgroundUVB induced cell cycle checkpoints in an early stage human melanoma line, WM35
Petrocelli, T., & Slingerland, J. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203808 · Cited by 38
“…kinase activities are required for initiation and maintenance of DNA replication (Pagano et al., 1992), while the cdk Oncogene inhibitor, p21, is implicated in S phase arrest following DNA damage (Chen et al., 1995, 1996; Flores-Rosas et al., 1994; Ogryzko et al., 1997; Waga et al., 1994).”
BackgroundJian, Y., Tine, B. A. V., Chien, W., Shaw, G. M., Tr, B., & Chow, L. (1999) · PubMed · Cited by 30
Zhang, M., Gan, L., & Ren, G. (2012) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2012007500035 · Cited by 27
Liu, W., Chen, Y., Lu, G., Sun, L., & Si, J. (2011) · BMC Gastroenterology · doi:10.1186/1471-230x-11-146 · Cited by 27
“The p21 protein can inhibit DNA synthesis by interacting with PCNA [21], and plays a regulatory role in S phase DNA replication and DNA damage repair [22].”
BackgroundInfluentialIdentification of Xenopus cyclin-dependent kinase inhibitors, p16Xic2 and p17Xic3
Daniels, M., Dhokia, V., Richard‐Parpaillon, L., & Ohnuma, S. (2004) · Gene · doi:10.1016/j.gene.2004.07.038 · Cited by 27
Requirement for PCNA and RPA in interstrand crosslink-induced DNA synthesis
Li, L., Peterson, C. A., Zhang, X., & Legerski, R. J. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.6.1424 · Cited by 32
Identification of a Novel 81-kDa Component of the Xenopus Origin Recognition Complex
Carpenter, P. B., & Dunphy, W. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.38.24891 · Cited by 31
The Temporal Regulation of S Phase Proteins During G1
Grant, G. D., & Cook, J. G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6955-0_16 · Cited by 34
“DREAM assembly is also facilitated in G0 because cyclin D/CDK4 (low in G0) can phosphorylate p130 to disrupt its incorporation into the DREAM complex (Sandoval et al. 2009).”
BackgroundInfluentialIntegration of the PRB and P53 Cell Cycle Control Pathways
Stewart, C. L., Soria, A. M., & Hamel, P. A. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010615822317 · Cited by 31
“There are six binding sites for p21 per PCNA trimer [185], therefore p21 can form either a quaternary complex with PCNA, cyclin and CDK or can bind to PCNA directly.”
Nakajima, A., Shimizu, S., Moriya, H., & Yamazaki, M. (2003) · Endocrinology · doi:10.1210/en.2003-0158 · Cited by 29
Chuang, L.-C., & Yew, P. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506429200 · Cited by 29
Takasaki, Y., Kogure, T., Takeuchi, K., Kaneda, K., Yano, T., Hirokawa, K., Hirose, S., Shirai, T., & Hashimoto, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4780 · Cited by 26
Diabetic LDL inhibits cell-cycle progression via STAT5B and p21waf
Brizzi, M. F., Dentelli, P., Pavan, M., Rosso, A., Gambino, R., Cesaris, M. G. D., Garbarino, G. M., Camussi, G., Pagano, G., & Pegoraro, L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13617 · Cited by 26
Redeuilh, G., Attia, A., Mešter, J., & Sabbah, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205753 · Cited by 28
“Apart from cyclin-dependent kinases, p21WAF1/CIP1/SDI1 (hereafter referred to as p21) can also directly prevent DNA synthesis by inhibiting DNA polymerase g and e (Chen et al., 1995; Zhang et al., 1993).”
BackgroundHuo, Y., Yeh, S.-D., & Lee, W. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105459 · Cited by 26
Progesterone inhibits human endothelial cell proliferation through a p53-dependent pathway
Hsu, S., Ho, P. Y., Juan, S., Liang, Y., & Lee, W.-S. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8441-3 · Cited by 27
Tsai, C., Lin, Y., Huang, C., Shih, C.-M., Tsai, Y.-T., Tsao, N.-W., Lin, C., Shih, C.-C., Jeng, H., & Lin, F. (2016) · Scientific Reports · doi:10.1038/srep38421 · Cited by 25
Tang, J., Shen, C., & Lu, Y. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9206-7 · Cited by 25
Cell cycle control of eukaryotic DNA replication
Kearsey, S. E., Labib, K. P. M., & Maiorano, D. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)80052-9 · Cited by 24
Correction: Up-Regulation of MicroRNA-21 Correlates with Lower Kidney Cancer Survival
Zaman, M. S., Shahryari, V., Deng, G., Thamminana, S., Saini, S., Majid, S., Chang, I., Hirata, H., Ueno, K., Yamamura, S., et al. (2012) · PLoS ONE · doi:10.1371/annotation/6662579f-3a41-4bce-9298-9d15f6582ef5 · Cited by 26
Song, W., Levin, D. S., Varkey, J., Post, S. M., Bermudez, V. P., Hurwitz, J., & Tomkinson, A. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703774200 · Cited by 28
Sanz-Gonzalez, S. M. (2000) · Frontiers in bioscience · doi:10.2741/sanz · Cited by 24
“In addition to its inhibitory effect on CDKs, p21 can also inhibit DNA replication through direct interaction with proliferating cell nuclear antigen (PCNA) (27, 28).”
BackgroundInfluentialMüller-Decker, K., Kopp-Schneider, A., Marks, F., Seibert, K., & Fürstenberger, G. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199809)23:1<36::aid-mc5>3.0.co;2-f · Cited by 109
Alterations in Skin and Stratified Epithelia by Constitutively Activated PPARα
Yang, Q., Yamada, A., Kimura, S., Peters, J. M., & Gonzalez, F. J. (2005) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700056 · Cited by 26
“The upregulation of p21 expression in the skin of transgenic mice expressing VP16PPARa is consistent with the observed arrest of primary keratinocytes in the G1 phase because p21 functions to block cell cycle progression in the S phase, due to its ability to bind to and inhibit proliferating cell nuclear antigen (Chen…”
BackgroundInhibition of p21/Waf1/Cip1/Sdi1 Expression by Hepatitis C Virus Core Protein
Yoshida, I., Oka, K., Hidajat, R., Nagano‐Fujii, M., Ishido, S., & Hotta, H. (2001) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2001.tb01303.x · Cited by 24
Yamato, K., Hashimoto, S., Okahashi, N., Ishisaki, A., Nonaka, K., Koseki, T., Kizaki, M., Ikeda, Y., & Nishihara, T. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4876 · Cited by 26
Association of p53 and CDKN1A genotypes with endometriosis.
Ying, T.-H., Tseng, C.-J., Tsai, S., Hsieh, S.-C., Lee, H., Hsieh, Y., & Bau, D. (2011) · PubMed · Cited by 23
Dietary NiCl2 causes G2/M cell cycle arrest in the broiler's kidney
Guo, H., Cui, H., Peng, X., Fang, J. S., Zuo, Z., Deng, J., Wang, X., Wu, B., Chen, K., & Deng, J. (2015) · Oncotarget · doi:10.18632/oncotarget.5934 · Cited by 23
“The protein expression of phosphorylated ataxia telangiectasia mutated (p-ATM), p53, p-Chk1, p-Chk2, p21 p-cdc25C, cdc2, cyclin B and proliferating cell nuclear antigen (PCNA) protein expression and the mRNA expression levels of nine genes involved in G2/M transition: ATM, p53, p21, Chk1, Chk2, cdc25, cdc2, cyclin B,…”
BackgroundInfluential(1997) · Trends in Genetics · doi:10.1016/0168-9525(97)90029-9 · Cited by 148
Maga, G., Blanca, G., Shevelev, I., Frouin, I., Ramadan, K., Spadari, S., Villani, G., & Hübscher, U. (2004) · The FASEB Journal · doi:10.1096/fj.04-2268fje · Cited by 23
“The p21protein is induced upon DNA damage, senescence or differentiation of cells, and blocks progression of the cell cycle through its interaction CDKs and PCNA (30, 31).”
Backgroundp16ink4aGene and Hematological Malignancies
Quesnel, B., Preudhomme, C., & Fenaux, P. (1996) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199609051724 · Cited by 25
The microarchitecture of DNA replication domains
Philimonenko, A. A., Hodný, Z., Jackson, D. A., & Hozák, P. (2005) · Histochemistry and Cell Biology · doi:10.1007/s00418-005-0090-0 · Cited by 23
“Later it was also demonstrated that p21 can inhibit DNA replication in vitro by directly binding to PCNA (Chen et al. 1995).”
BackgroundYang, V. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00008-6 · Cited by 27
Recombinant HE4 protein promotes proliferation of pancreatic and endometrial cancer cell lines
Lu, Q., Chen, H.-B., Senkowski, C. K., Wang, J., WANG, X., Brower, S. T., Glasgow, W. C., Byck, D. B., Jiang, S., & Li, J. (2015) · Oncology Reports · doi:10.3892/or.2015.4339 · Cited by 22
P53 and Rb tumor suppressor gene alterations in gastric cancer
Mattar, R., Nonogaki, S., Silva, C., Alves, V. A. F., & Gama-Rodrigues, J. J. (2004) · Revista do Hospital das Clínicas · doi:10.1590/s0041-87812004000400004 · Cited by 22
p21 (WAF1/CIP1) Is Required for the Mitogenic Response to Intestinal Resection
Stern, L. E., Falcone, R. A., Kemp, C. J., Erwin, C. R., & Warner, B. W. (2000) · Journal of Surgical Research · doi:10.1006/jsre.2000.5834 · Cited by 22
“These two modes of action are restricted to particular domains of the p21 protein, with Cdk inhibitory activity contained within the N-terminus and PCNA inhibition located within the C-terminus region [18].”
BackgroundBall, K. L., & Lane, D. P. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0854p.x · Cited by 24
“These results have been confirmed by deletion/mutation analysis (Chen et al., 1995; Goubin and Ducommun, 1995) We have presented data that suggests that the p2IWAF'-responsive regulatory domain of PCNA is conserved between plants and animals.”
BackgroundResultHall, J. R., Bereman, M. S., Nepomuceno, A. I., Thompson, E. A., Muddiman, D. C., & Smart, R. C. (2014) · Cell Cycle · doi:10.4161/15384101.2014.962957 · Cited by 21
Dual Regulatory Roles of Human AP-Endonuclease (APE1/Ref-1) in CDKN1A/p21 Expression
Sengupta, S., MITRA, S. P., & Bhakat, K. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068467 · Cited by 23
“Stress-induced p53-mediated activation of p21 causes cell cycle arrest at specific stages (G1/S or G2/M) of the cell cycle by inhibiting cyclin-dependent kinases and also interferes with PCNA-dependent DNA polymerase activity thereby inhibiting DNA replication [37,39,53,54,55].”
BackgroundYan, F., Gou, L., Yang, J., Chen, L., Tong, A., Tang, M., Yuan, Z., Yao, S., Zhang, P., & Wei, Y. (2008) · Biochimie · doi:10.1016/j.biochi.2008.12.002 · Cited by 21
Li, Y., Barbash, O., & Diehl, J. A. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00011-1 · Cited by 28
Sheaff, R. J., & Roberts, J. M. (1998) · Results and problems in cell differentiation · doi:10.1007/978-3-540-69686-5_1 · Cited by 22
Cyclin-dependent kinase inhibitors: the age of crystals
Pines, J. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(96)00042-x · Cited by 29
Jackson, S. K., DeLoose, A., & Gilbert, K. M. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01457.x · Cited by 21
Sweeney, K. J. E., Musgrove, E. A., Watts, C. K. W., & Sutherland, R. L. (1996) · Cancer treatment and research · doi:10.1007/978-1-4613-1259-8_8 · Cited by 22
Diabetic LDL inhibits cell-cycle progression via STAT5B and p21waf
Brizzi, M. F., Dentelli, P., Pavan, M., Rosso, A., Gambino, R., Cesaris, M. G. D., Garbarino, G. M., Camussi, G., Pagano, G., & Pegoraro, L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213617 · Cited by 21
Adeyemi, R. O., Fuller, M. S., & Pintel, D. J. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004055 · Cited by 20
“p21 interaction with PCNA has been shown to interfere with DNA polymerase d2mediated cellular DNA replication [5,6].”
BackgroundFunaoka, K., Shindoh, M., Yamashita, T., Fujinaga, K., Amemiya, A., & Totsuka, Y. (1996) · Cancer Letters · doi:10.1016/s0304-3835(96)04362-5 · Cited by 20
In Vitro Induction of Differentiation by Ginsenoside Rh2 in SMMC‐7721 Hepatocarcinoma Cell Line
Zeng, X., & Tu, Z. (2003) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.2003.pto930605.x · Cited by 20
Bao, G. C., Wang, J., & Jong, A. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.05.052 · Cited by 20
Cyclin-dependent kinase inhibitors (CKIs) and hematological malignancies
Baghdassarian, N., & Ffrench, M. (1996) · Hematology and Cell Therapy · doi:10.1007/s00282-996-0313-4 · Cited by 21
“are responsible for interacting with and inhibiting the different targets of this protein [ 6 , 13].”
BackgroundCarboxyl-terminal Domain of p27Kip1 Activates CDC2
Üren, A., Jakus, J., de Mora, J. F., Yeudall, W. A., Santos, E., Gutkind, J. S., & Heidaran, M. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.21669 · Cited by 20
Vorhauser, J., Roumeliotis, T. I., Coupe, D., Leung, J. K., Yu, L., Böhlig, K., Zerjatke, T., Glauche, I., Nadler, A., Choudhary, J. S., et al. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.07.023 · Cited by 22
Molecular mediators involved in Ferulago campestris essential oil effects on osteoblast metabolism
Sabbieti, M. G., Agas, D., Maggi, F., Vittori, S., & Marchetti, L. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23306 · Cited by 19
“The cell cycle progression is negatively regulated by two families of cyclin-dependent kinase inhibitors (CKIs) [Sherr and Roberts, 1999], which include p21Cip/WAF1 protein [Chen et al., 1995; Fotedar et al., 1996].”
BackgroundParroche, P., Touka, M., Mansour, M., Bouvard, V., Thepot, A., Accardi, R., Carreira, C., Roblot, G., Sylla, B. S., Hasan, U. A., et al. (2011) · Virology · doi:10.1016/j.virol.2011.05.016 · Cited by 19
“Furthermore, it has been shown that p21WAF1 can bind to PCNA (proliferating-cell nuclear antigen), an essential DNA replication factor, and this binding is sufficient for the inhibition of DNA replication based on simian virus 40 (Chen et al., 1995).”
BackgroundStoichiometry of Cyclin A−Cyclin-Dependent Kinase 2 Inhibition by p21Cip1/Waf1
Adkins, J., & Lumb, K. J. (2000) · Biochemistry · doi:10.1021/bi001524e · Cited by 25
Phylogenetic analysis of archaeal PCNA homologues
Iwai, T., Kurosawa, N., ITOH, Y. H., & Horiuchi, T. (2000) · Extremophiles · doi:10.1007/s007920070005 · Cited by 19
Engidawork, E., Gulesserian, T., Seidl, R., Cairns, N. J., & Lübec, G. (2001) · Springer eBooks · doi:10.1007/978-3-7091-6262-0_14 · Cited by 21
Mikecin, A., Walker, L. R., Kuna, M., & Raucher, D. (2013) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000036 · Cited by 18
EAPP: Gatekeeper at the crossroad of apoptosis and p21-mediated cell-cycle arrest
Andorfer, P., & Rotheneder, H. (2011) · Oncogene · doi:10.1038/onc.2010.639 · Cited by 19
“…is the CDKN1A gene that codes for p21 (or p21WAF1/Cip1), which induces growth arrest by binding and inhibiting CDK complexes (el-Deiry et al., 1993; Chen et al., 1995; Goubin and Ducommun, 1995) and by sequestering away proliferating cell nuclear antigen from DNA polymerase d (Flores-Rozas et al.,…”
BackgroundKim, K. M., Cho, H., & Kim, Y. K. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.135 · Cited by 18
Andrés, V. (1998) · Frontiers in bioscience · doi:10.2741/a240 · Cited by 22
Rand, A., Glenn, K. S., Alvares, C., White, M. B., Thibodeau, S. M., & Karnes, W. E. (1996) · Cancer Letters · doi:10.1016/s0304-3835(06)80030-3 · Cited by 18
Nguyên, V., Candal, E., Sharif, A., Joly, J., & Bourrat, F. (2001) · Developmental Dynamics · doi:10.1002/dvdy.1203 · Cited by 20
“An example, p21CIP1 binds the PCNA (Waga et al., 1994; Chen et al., 1995; Luo et al., 1995).”
Mutation and mutagenesis in inherited and acquired human disease
Evans, H. J. (1996) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(95)00201-4 · Cited by 17
Expression of p21WAF1/CIP1 in fetal and adult tissues: simultaneous analysis with Ki67 and p53.
Mateo, M. S., Sáez, A. I., Sánchez‐Beato, M., Garcia, P., Sánchez‐Verde, L., Martinez, J. C., Orradre, J. L., & Piris, M. A. (1997) · Journal of Clinical Pathology · doi:10.1136/jcp.50.8.645 · Cited by 21
BDNF accelerates gene expression in cultured cerebellar granule neurons
Lin, X., Cui, H., & Bulleit, R. F. (1998) · Developmental Brain Research · doi:10.1016/s0165-3806(97)00193-4 · Cited by 17
KLHL4, a novel p53 target gene, inhibits cell proliferation by activating p21
Choi, S., Cho, S.-Y., Song, J.-Y., & Hur, M. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.07.100 · Cited by 19
Acharya, S., Chatterjee, S., Kumar, P., Bhattacharjee, M., Chaudhuri, S., & Chaudhuri, S. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32833276e8 · Cited by 18
CAI, L., Ye, H., Li, X., Lin, Y., YU, F., Chen, J., Li, H., & Liu, X. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1816 · Cited by 19
Self-citation
Metadata
- Authors
- Chen, J., Jackson, P. K., Kirschner, M. W., & Dutta, A.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Venue
- Nature
- Published
- 1995-03
- Volume
- 374
- Issue
- 6520
- Pages
- 386-388
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2078690152
- Cited by
- 548
- References
- 16
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 5 · 2021: 6 · 2020: 6 · 2019: 9 · 2018: 7 · 2017: 5 · 2016: 6 · 2015: 10 · 2014: 9 · 2013: 10 · 2012: 20
- FWCI
- 24.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- p21, WAF1/CIP1, p53, PCNA, proliferating cell nuclear antigen, protein domains, N-terminal domain, C-terminal domain, DNA replication inhibition, cell cycle arrest, growth inhibition, tumour suppressor
- MeSH terms
- Animals, Haplorhini, Binding Sites, Cell Division, Cell Line, Transformed, DNA Replication, Escherichia coli, Humans, Peptide Fragments, Recombinant Fusion Proteins, Simian virus 40, Tumor Cells, Cultured, Xenopus, Cyclins, Protein Serine-Threonine Kinases, Proliferating Cell Nuclear Antigen, Cyclin-Dependent Kinases, Xenopus Proteins, CDC2-CDC28 Kinases, Cyclin-Dependent Kinase Inhibitor p21, Cyclin-Dependent Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.